Sign in
NM

New Mountain Finance Corp (NMFC)·Q2 2025 Earnings Summary

Executive Summary

  • NMFC delivered adjusted NII of $0.32 per share, covering the $0.32 dividend; GAAP diluted EPS was $0.07 as unrealized marks weighed on results. Total investment income (TII) was $83.49M. EPS matched consensus (in line), while revenue came in modestly below consensus ($83.49M vs $84.57M). NAV/share fell to $12.21 from $12.45 in Q1 and $12.55 in Q4.
  • Mix and credit quality remained solid: ~78% senior-oriented assets, ~95% of the portfolio rated green; non‑accruals at 1.2% of FV. Weighted average YTM at cost ~10.6%.
  • Management reaffirmed the dividend protection program through 2026 and again declared a $0.32 distribution for Q3 2025; the firm repurchased $9.6M in shares in Q2 and cites a ~15% discount to book as attractive, positioning buybacks and liability refinancings as catalysts.
  • Macro/micro puts and takes: tight spreads and softer fee income persist, while deal activity shows signs of “unfreezing.” A tariff-exposed consumer products borrower moved to red (still current on interest) and select valuation pressures (e.g., Edmentum equity) drove NAV down q/q.

What Went Well and What Went Wrong

  • What Went Well

    • Dividend covered by adjusted NII; Q3 2025 dividend declared at $0.32 with protection program support through 2026. “Adjusted net investment income for the quarter was $0.32 per share covering our $0.32 per share dividend.”
    • Portfolio quality and mix: ~95% of assets rated green; senior-oriented assets increased to ~78%; YTM at cost ~10.6%.
    • Capital allocation and alignment: $9.6M of buybacks in Q2; management cites ~15% discount to book as compelling; continued focus on refinancing higher-cost debt and optimizing floating-rate liability mix.
    • Quote: “We continued to advance our strategic priorities... increasing the percentage of senior-oriented assets to nearly 80% and building more position diversification.” (CEO John Kline)
  • What Went Wrong

    • NAV declined to $12.21 from $12.45 driven by marks on select positions (Edmentum equity accretion ahead of NMFC position; dental practice headwinds; tariff-impacted consumer product name).
    • Slight revenue shortfall vs consensus; tight spreads and lower fee income pressure earnings power absent protection.
    • Tariffs: one consumer products borrower moved from yellow to red; liquidity support may be required (sponsor/lenders).

Financial Results

Income statement trends (oldest → newest)

MetricQ4 2024Q1 2025Q2 2025
Total Investment Income ($USD Millions)$91.0 $85.66 $83.49
Adjusted NII per Share ($)$0.32 $0.32 $0.32
Net Investment Income ($USD Millions)$34.5 $34.64 $34.59
GAAP Diluted EPS ($)$0.22 $0.07

Year-over-year (Q2 to Q2)

MetricQ2 2024Q2 2025
Total Investment Income ($USD Millions)$94.59 $83.49
Adjusted NII per Share ($)$0.36 $0.32

Margins

MetricQ4 2024Q1 2025Q2 2025
Net Income Margin %30.35%*27.33%*9.31%*

*Values retrieved from S&P Global.

Estimates vs Actuals (Q2 2025)

MetricConsensusActual
Primary EPS (Adjusted NII/share)$0.32$0.32
Primary EPS – # of Estimates7
Revenue (Total Investment Income, $USD Millions)$84.57$83.49
Revenue – # of Estimates6

KPIs and balance sheet (oldest → newest)

KPIQ4 2024Q1 2025Q2 2025
NAV per Share ($)$12.55 $12.45 $12.21
Portfolio FV ($USD Billions)$3.10 $3.05 $3.01
Statutory Debt/Equity1.15x 1.15x 1.17x
Senior-Oriented Assets (%)~75% ~77% ~78%
Non‑accruals (% of FV)1.2% 1.2% 1.2%
Weighted Avg YTM at Cost~11.0% ~10.2% ~10.6%
PIK Interest as % of TII10% 8% 14%
Floating Rate Mix (Assets/Liabilities)86%/49% 85%/50% 86%/49% (moving to ~81%/19% PF)

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Dividend per ShareQ3 2025$0.32 (implied run-rate) $0.32 declared; pay 9/30/2025Maintained
Dividend Protection Program2025–2026In place for 2025–2026 Reaffirmed; can waive fees incrementally as needed Maintained
Liability Optimization2H 2025Intend to refinance 7.5% converts & 8.25% notes when callable Preparing to refinance both in Q4; plan to hedge rates Execution path detailed
SBIC CapacityJuly 2025Received third SBIC licenseNew capacity

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4’24 and Q1’25)Current Period (Q2’25)Trend
Tariffs/MacroMinimal tariff exposure; one small exposure identified; spreads tight but stable One consumer products borrower moved to red due to tariffs and prior underperformance; liquidity likely needed Deteriorated for single name; portfolio-wide exposure still limited
PIK ReductionCommitment to prudent PIK levels; plan to reduce PIK interest 8% of TII in Q1; target low-teens longer term Collected ~$8M PIK; further monetizations planned
Liability OptimizationRaised IG bonds, repriced Wells ABL; aim to increase floating mix Repriced Wells to SOFR+1.95% in Q1 Prepare to refi converts/baby bonds; move to ~81% floating liabilities pro forma
Senior-Oriented Mix~75% senior ~77% senior ~78% senior
Deal Flow/SpreadsTight spreads; episodic activity; 2025 pickup expected Stable spreads, some OID uptick; portfolio rotations Signs of “unfreezing,” pipeline improving
Sector Notes (Healthcare)No red names; diverse sectors Dental practice headwinds; veterinary seen as healthier; deprioritizing some physician services lending Mixed

Management Commentary

  • “Adjusted net investment income for the quarter was $0.32 per share covering our $0.32 per share dividend… Our net asset value per share of $12.21 declined $0.24 compared to Q1.” — Steven Klinsky
  • “We continued to advance our strategic priorities… increasing the percentage of senior-oriented assets to nearly 80% and building more position diversification across the portfolio.” — John Kline
  • “The dividend protection program is meant to be a form of shareholder support… we’re committed to keeping the program in place through 2026.” — John Kline
  • “Perhaps the most notable movement was the migration from yellow to red of a consumer products company… impacted by tariffs… [it] will need liquidity support before year end.” — John Kline
  • “Pro forma for the expected upcoming refinancing activity… we expect our [liability] mix will shift meaningfully to 81% floating and 19% fixed.” — Laura Holson

Q&A Highlights

  • Healthcare lens: Dental business pressures are largely idiosyncratic and execution‑sensitive; veterinary remains attractive (cash pay, secular tailwinds). NMFC is de‑emphasizing some physician services lending on a go‑forward basis.
  • Dividend protection mechanics: Management will use the protection program and incremental fee waivers “as needed” to maintain the $0.32 dividend amid tight spreads/fee headwinds, while pursuing core earnings catalysts (liability refi, new SBIC, buybacks).
  • Tariff‑exposed borrower: The red‑rated consumer products name was previously flagged; tariffs compounded prior operational underperformance. Management remains optimistic on long‑term recovery but expects near‑term liquidity needs (sponsor or lender support).
  • Outlook on spreads and activity: Spreads largely stable; signs of increasing deal activity should support originations and fee income into 2H25.

Estimates Context

  • Q2 2025 EPS matched consensus ($0.32 vs $0.32), supported by recurring income and fee waivers; revenue was a modest miss ($83.49M actual vs $84.57M consensus). Primary EPS estimates: 7 contributors; revenue estimates: 6 contributors. Management continues to position capital structure and mix to offset tight spreads and potential base rate headwinds.
    Sources: S&P Global consensus; actuals from company materials.

Key Takeaways for Investors

  • Dividend intact; coverage supported by recurring income plus the protection program through 2026. The newly declared $0.32 Q3 dividend and >12% yield remain core to the story.
  • Slight top‑line miss but EPS in line: TII softness reflects tight spreads/fees, while adjusted EPS stability highlights cost actions and fee waivers. Watch for revenue re‑acceleration as deal activity improves.
  • NAV drift reflects idiosyncratic valuation pressures (tariff‑exposed consumer products, Edmentum capital structure), not broad credit deterioration; non‑accruals remain low at 1.2% of FV.
  • Mix and liability catalysts: rising senior orientation (~78%), new SBIC license, and planned refinancing of 7.5% converts/8.25% notes should support net interest earnings and reduce funding costs.
  • Capital allocation adds upside: active buybacks at a ~15% discount to NAV and portfolio rotations from equity/PIK into cash‑yielding first‑liens can compound total return.
  • Risk monitor: tariffs on China‑centric supply chains; healthcare execution (dental) pockets; base‑rate decline scenario could pressure earnings—management is aligning floating liabilities to mitigate.
  • Trading lens: The narrative centers on durable income, visible dividend support, and liability/mix optimization amid improving activity. Stock reaction catalysts include announced refinancings, further PIK monetizations, and additional repurchase activity.

Supporting detail and source documents:

  • Q2 2025 press release and 8‑K Item 2.02 (Ex. 99.1): adjusted NII/share, TII, NAV/share, mix, SBIC license, dividend declaration, financial statements.
  • Q2 2025 earnings call: portfolio quality, tariff‑exposed borrower, sector updates, liability plans, PIK monetization, buybacks, dividend protection program.
  • Prior quarters (trend): Q1 2025 and Q4 2024 press releases and calls for mix, spreads, PIK, NAV, and TII trajectory.